Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have earned an average rating of “Buy” from the eight ratings firms that are covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have updated their coverage on the […]
HC Wainwright reiterated their buy rating on shares of Sutro Biopharma (NASDAQ:STRO – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $12.00 target price on the stock. HC Wainwright also issued estimates for Sutro Biopharma’s Q2 2024 earnings at ($0.99) EPS, Q3 2024 earnings at ($1.01) EPS, Q4 […]
Oppenheimer restated their outperform rating on shares of Sutro Biopharma (NASDAQ:STRO – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. The brokerage currently has a $10.00 target price on the stock. STRO has been the topic of a number of other reports. Piper Sandler reaffirmed an overweight rating and […]
Sutro Biopharma (NASDAQ:STRO) Rating Reiterated by HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Sutro Biopharma (NASDAQ:STRO) Receives Overweight Rating from Piper Sandler themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.